ZEG
ASTRAZENECA PLC DL,25
Stock XETRA – Stock Market Prices, News & Analysis
Société pharmaceutique globale qui développe et commercialise des médicaments principalement dans les domaines de l'oncologie, des maladies cardiovasculaires et respiratoires.
ASTRAZENECA PLC DL,25
ZEG
Société pharmaceutique globale qui développe et commercialise des médicaments principalement dans les domaines de l'oncologie, des maladies cardiovasculaires et respiratoires.
Price history of ASTRAZENECA PLC DL,25
Price history of ASTRAZENECA PLC DL,25
Performance & Momentum
Strategic Analysis
ASTRAZENECA PLC DL,25 • 2026
AstraZeneca positions itself as a major player in the global pharmaceutical industry, specializing in the development of innovative drugs in oncology, cardiovascular diseases, and respiratory conditions. Its model is based on strong innovation capabilities and an extensive commercial presence, supported by active medical research and deep biotechnology expertise.
Strengths
- Diversified portfolio focused on therapeutic segments with strong growth and high unmet medical need
- Robust R&D pipeline supported by significant investments in biotechnology
- Balanced global presence facilitating access to both emerging and mature markets
Weaknesses
- Costly and uncertain development of new molecules
- Exposure to strict pharmaceutical regulation and pricing pressure
Momentum
Positive medium-term momentum reflects good operational resilience and renewed investor interest, supported by solid results and a favorable environment for healthcare innovation. This dynamic supports an investment strategy focused on long-term growth within the pharmaceutical sector.
Similar stocks to ASTRAZENECA PLC DL,25
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
